The dual substrate specificity of aldehyde oxidase 1 for retinal and acetaldehyde and its role in ABCA1 mediated efflux

Hormone and Metabolic Research

Volumn 39, Issue 11, 2007, Pages 775-776

  Graessler, J ^a   Fischer, S ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ACETALDEHYDE; ALDEHYDE OXIDASE; ALDEHYDE OXIDASE 1; HIGH DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINAL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CARDIOVASCULAR RISK; EDITORIAL; ENZYME SPECIFICITY; HAPLOTYPE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY;

ACETALDEHYDE; ALDEHYDE OXIDASE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DIETARY FATS; HUMANS; ISOENZYMES; LIPOPROTEINS, HDL; RETINALDEHYDE; SUBSTRATE SPECIFICITY;

EID: 36749103200     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992126     Document Type: Editorial

References (35)

1. Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Metabolic syndrome and the endocrine stress system. Horm Metab Res 2006; 38: 437-441
2. Ishikawa K, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y. Subcutaneous fat modulates insulin sensitivity in mice by regulating TNF-alpha expression in visceral fat. Horm Metab Res 2006; 38: 631-638
3. Sell H, Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol 2007; 18: 258-262
4. Shibasaki M, Bujo H, Takahashi K, Murakami K, Unoki H, Saito Y. analytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice. Horm Metab Res 2006; 38: 491-496
5. Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology 2007; 132: 2181-2190
6. Kraus D, Jager J, Meier B, Fasshauer M, Klein J. Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res 2005; 37: 455-459
7. Heliovaara MK, Strandberg TE, Karonen SL, Ebeling P. Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans. Horm Metab Res 2006; 38: 336-340
8. Schwarz PE, Govindarajalu S, Towers W, Schwanebeck U, Fischer S. Vasseur F, Bornstein SR, Schulze J. Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm Metab Res 2006; 38: 447-454
9. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568
10. Ferris WF, Naran NH, Crowther NJ, Rheeder P, Merwe L van der, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005; 37: 695-701
11. Oramy F, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005; 85: 1343-1372
12. Nugent C, Younossi ZM. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 432-441
13. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22: 347-351
14. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, Dam M van, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest Jr J, Hayden MR. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22: 336-345
15. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22: 352-355
16. Beedham C, Critchley DJ, Rance DJ. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon. Arch Biochem Biophys 1995; 319: 481-490
17. Wright RM, Clayton DA, Riley MG, MacManaman JL, Repine JE. cDNA cloning, sequencing, and characterization of male and female rat liver aldehyde oxidase (rAOX1). Differences in redox status may distinguish male and female forms of hepatic APX. J Biol Chem 1999; 274: 3878-3886
18. Calzi ML, Raviolo C, Ghibaudi E, Gioia L de, Salmona M, Cazzaniga C, Kurosaki M, Terao M, Garattini E. Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J Biol Chem 1995; 270: 31037-31045
19. Tomita S, Tsujita M, Ichikawa Y. Retinal oxidase is identical to aldehyde oxidase. FEBS Lett 1993; 336: 272-274
20. Huang DY, Ichikawa Y. Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol. Biochem Biophys Res Commun 1994; 205: 1278-1283
21. Terao M, Kurosaki M, Barzago MM, Varasano E, Boldetti A, Bastone A, Fratelli M, Garattini E. Avian and Canine Aldehyde Oxidases: Novel insights into the biology and evolution of molybdo-flavoenzymes. J Biol Chem 2006; 281: 19748-19761
22. Langmann T, Liebisch G, Moehle C, Schifferer R, Dayoub R, Heiduczek S, Grandl M, Dada A, Schmitz G. Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim Biophys Acta 2005; 1740: 155-161
23. Moriwaki Y, Yamamoto T, Higashino K. Distribution and pathophysiologic role of molybdenum-containing enzymes. Histol Histopathol 1997; 12: 513-524
24. Bondy SC, Orozco J. Effects of ethanol treatment upon sources of reactive oxygen species in brain and liver. Alcohol Alcohol 1994; 29: 375-383
25. Shaw S, Jayatilleke E. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat. Biochem J 1990; 268: 579-583
26. Shaw S, Jayatilleke E. The role of cellular oxidases and catalytic iron in the pathogenesis of ethanol-induced liver injury. Life Sci 1992; 50: 2045-2052
27. Shaw S, Jayatilleke E. Cimetidine as a scavenger of ethanol-induced free radicals. Alcohol 1992; 9: 363-367
28. Shaw S, Eng J, Jayatilleke E. Ethanol-induced free radical injury to the hepatocyte glucagon receptor. Alcohol 1995; 12: 273-277
29. Wright RM, Riley MG, Weigel LK, Ginger LA, Costantino DA, MacManaman JL. Activation of the human aldehyde oxidase (hAOX1) promoter by tandem cooperative Sp1/Sp3 binding sites: identification of complex architecture in the hAOX upstream DNA that includes a proximal promoter, distal activation sites, and a silencer element. DNA Cell Biol 2000; 19: 459-474
30. Mira L, Mala L, Barreira L, Manso CF. Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism. Arch Biochem Biophys 1995; 318: 53-58
31. Wright RM, Weigel LK, Repine JE. Aldehyde oxidase generates deoxyribonucleic acid single strand nicks in vitro. Redox Rep 1995; 1: 313-324
32. Wang XD. Alcohol, vitamin A, and cancer. Alcohol 2005; 35: 251-258
33. Volcik K, Ballantyne CM, Pownall HJ, Sharrett AR, Boerwinkle E. Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study. J Stud Alcohol Drugs 2007; 68: 485-492
34. Marmillot P, Munoz J, Patel S, Garige M, Rosse RB, Lakshman MR. Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans. Metabolism 2007; 56: 947-953
35. Goude D, Fagerberg B, Hulthe J. Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men (AIR study). Clin Sci (Lond) 2002; 102: 345-352